NEOART

The NeoART trial is for patients with Stage II/III bowel cancer (cancer that has not spread to other organs) who are waiting for an operation to remove their cancer. Our aim is to determine whether taking a 2 week course of oral artesunate 200mg daily prior to surgery can improve survival rates and reduce the risk of the cancer coming back after surgery. This study will compare 2 groups of patients: those who take artesunate with those who take a matching placebo (dummy pill).

Also known as: NeoART TRIAL

Registration numbers: 1117241 (W)